Another study by Shirakabe et al. [105] among patients with worsening renal failure showed H-FABP as a more effective marker for predicting adverse long-term outcomes, especially in patients with HF as an inclusion criterion [105]. The gene discussed is FABP3; the disease is hydrops fetalis.